507 related articles for article (PubMed ID: 26903545)
1. Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia.
Bär C; Povedano JM; Serrano R; Benitez-Buelga C; Popkes M; Formentini I; Bobadilla M; Bosch F; Blasco MA
Blood; 2016 Apr; 127(14):1770-9. PubMed ID: 26903545
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of telomere attrition in patients with aplastic anemia.
Scheinberg P
Int J Hematol; 2013 May; 97(5):553-7. PubMed ID: 23636667
[TBL] [Abstract][Full Text] [Related]
3. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
Yamaguchi H; Calado RT; Ly H; Kajigaya S; Baerlocher GM; Chanock SJ; Lansdorp PM; Young NS
N Engl J Med; 2005 Apr; 352(14):1413-24. PubMed ID: 15814878
[TBL] [Abstract][Full Text] [Related]
4. Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation.
Ziegler P; Schrezenmeier H; Akkad J; Brassat U; Vankann L; Panse J; Wilop S; Balabanov S; Schwarz K; Martens UM; Brümmendorf TH
Ann Hematol; 2012 Jul; 91(7):1115-20. PubMed ID: 22476886
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic and microenvironmental alterations in bone marrow associated with ROS in experimental aplastic anemia.
Chatterjee R; Law S
Eur J Cell Biol; 2018 Jan; 97(1):32-43. PubMed ID: 29173808
[TBL] [Abstract][Full Text] [Related]
6. Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice.
Raval A; Behbehani GK; Nguyen le XT; Thomas D; Kusler B; Garbuzov A; Ramunas J; Holbrook C; Park CY; Blau H; Nolan GP; Artandi SE; Mitchell BS
PLoS One; 2015; 10(7):e0131722. PubMed ID: 26133370
[TBL] [Abstract][Full Text] [Related]
7. Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.
Polychronopoulou S; Koutroumba P
Acta Haematol; 2004; 111(3):125-31. PubMed ID: 15034232
[TBL] [Abstract][Full Text] [Related]
8. AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer.
Muñoz-Lorente MA; Martínez P; Tejera Á; Whittemore K; Moisés-Silva AC; Bosch F; Blasco MA
PLoS Genet; 2018 Aug; 14(8):e1007562. PubMed ID: 30114189
[TBL] [Abstract][Full Text] [Related]
9. Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita.
Beier F; Foronda M; Martinez P; Blasco MA
Blood; 2012 Oct; 120(15):2990-3000. PubMed ID: 22932806
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of androgen therapy in a mouse model of aplastic anemia produced by short telomeres.
Bär C; Huber N; Beier F; Blasco MA
Haematologica; 2015 Oct; 100(10):1267-74. PubMed ID: 26206796
[TBL] [Abstract][Full Text] [Related]
11. Telomere maintenance and human bone marrow failure.
Calado RT; Young NS
Blood; 2008 May; 111(9):4446-55. PubMed ID: 18239083
[TBL] [Abstract][Full Text] [Related]
12. Telomere dysfunction and hematologic disorders.
Paiva RM; Calado RT
Prog Mol Biol Transl Sci; 2014; 125():133-57. PubMed ID: 24993701
[TBL] [Abstract][Full Text] [Related]
13. Erosion of telomeric single-stranded overhang in patients with aplastic anaemia carrying telomerase complex mutations.
Calado RT; Regal JA; Kajigaya S; Young NS
Eur J Clin Invest; 2009 Nov; 39(11):1025-32. PubMed ID: 19674077
[TBL] [Abstract][Full Text] [Related]
14. iPSC modeling of severe aplastic anemia reveals impaired differentiation and telomere shortening in blood progenitors.
Melguizo-Sanchis D; Xu Y; Taheem D; Yu M; Tilgner K; Barta T; Gassner K; Anyfantis G; Wan T; Elango R; Alharthi S; El-Harouni AA; Przyborski S; Adam S; Saretzki G; Samarasinghe S; Armstrong L; Lako M
Cell Death Dis; 2018 Jan; 9(2):128. PubMed ID: 29374141
[TBL] [Abstract][Full Text] [Related]
15. Telomere length is inherited with resetting of the telomere set-point.
Chiang YJ; Calado RT; Hathcock KS; Lansdorp PM; Young NS; Hodes RJ
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10148-53. PubMed ID: 20479226
[TBL] [Abstract][Full Text] [Related]
16. Elevated senescence in the bone marrow mesenchymal stem cells of acquired aplastic anemia patients: A possible implication of DNA damage responses and telomere attrition.
Saxena P; Srivastava J; Rai B; Tripathy NK; Raza S; Sinha RA; Gupta R; Yadav S; Nityanand S; Chaturvedi CP
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167025. PubMed ID: 38237741
[TBL] [Abstract][Full Text] [Related]
17. Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1.
Guo Y; Kartawinata M; Li J; Pickett HA; Teo J; Kilo T; Barbaro PM; Keating B; Chen Y; Tian L; Al-Odaib A; Reddel RR; Christodoulou J; Xu X; Hakonarson H; Bryan TM
Blood; 2014 Oct; 124(18):2767-74. PubMed ID: 25205116
[TBL] [Abstract][Full Text] [Related]
18. Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs.
Winkler T; Hong SG; Decker JE; Morgan MJ; Wu C; Hughes WM; Yang Y; Wangsa D; Padilla-Nash HM; Ried T; Young NS; Dunbar CE; Calado RT
J Clin Invest; 2013 May; 123(5):1952-63. PubMed ID: 23585473
[TBL] [Abstract][Full Text] [Related]
19. Telomeres and marrow failure.
Calado RT
Hematology Am Soc Hematol Educ Program; 2009; ():338-43. PubMed ID: 20008219
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
